TMB-365 and TMB-380 in Suppressed HIV-1 Infected Individuals

Clinical trial NCT05275998 · COMPLETED

Trial details

NCT number: NCT05275998
Sponsor: TaiMed Biologics Inc.
Status: COMPLETED
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

HIV-1-infection

Start date: 2022-07-05
Primary completion: 2024-11-20
Enrollment: 51

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.